Sissetulev dokumentAvalik
Kiri
Terviseamet · 13. november 2024
- Viit
- 11.1-2/24/11598-4
- Registreeritud
- 13. november 2024
- Dokumendi liik
- Sissetulev dokument
- Adressaat
- Abbott Laboratories Poland
- Saabumis/saatmisviis
- e-post
- Funktsioon
- 11.1 SULETUD 2025 Turustamise järgne järelevalve (post-marketing surveillance)
- Sari
- 11.1-2 Kirjavahetus Eesti turule lastavatest/kasutusele võetavatest/levitatavatest seadmetest MSA kaudu teavitamiseks
- Toimik
- 11.1-2/2023
- Vastutaja
- Karl Kalev Türk (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond)
Sisu (failidest)
Saatja: Adamczyk, Emilia <[email protected]>
Saaja: Meditsiiniseadmed (Medical Devices), RegulatoryEUEFTA
Teema: Manually access to EMDDB
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
Dear All,
To fulfill Estonian law regarding notification of medical devices I need to get an access to EMDDB.
As I’m a user outside Estonia and represent foreign Distributor for medical devices, I can not login into the EMDDB with the ID-card or by mobile-ID.
Kindly request to give me an access to database with username and password.
Best regards/Pozdrawiam,
Emilia
[Abbott Logo]
Emilia Adamczyk
Regulatory Affairs Specialist
Regulatory Affairs EU & EFTA
International Regulatory Affairs
Core Diagnostics
Abbott Laboratories Poland
Postępu 21B
02-676 Warszawa
Poland
O:
+48 22 319 13 26
F:
+48 22 319 1201
M:
+48 887117397
[email protected]<mailto:[email protected]>
This communication may contain information that is proprietary, confidential, or exempt from disclosure. If you are not the intended recipient, please note that any other dissemination, distribution, use or copying of this communication is strictly prohibited. Anyone who receives this message in error should notify the sender immediately by telephone or by return e-mail and delete it from his or her computer.